Internal Medicine, Infectious Disease · Louisville, KY
NPI
1477840957
Since 2011
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
234 E Gray St, Suite 768
Louisville, KY, 40202
Phone (502) 394-6470
Groups this clinician bills Medicare through
Medicare paid, 2024
$29K
438 services
Medicare patients, 2024
236
Average age 69
Drug cost, 2024
$4.1M
2,388 prescriptions
Company payments, 2025
$528
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey S Reeves was code 99214 (office e&m - established), 351 times for 200 patients. In total Jeffrey S Reeves billed 438 services in 10 codes, and Medicare paid $29K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-01-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 351 | 200 | $69.21 | $24K |
| 99213 Office E&M - Established | Facility | 47 | 44 | $39.66 | $1,864 |
| 99204 Office E&M - New | Facility | 13 | 13 | $99.23 | $1,290 |
By year: 2022 $45K for 692 services; 2023 $38K for 578 services; 2024 $29K for 438 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 49 | 38 | $2.97 | $146 |
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey S Reeves prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 325 prescriptions and refills. In total Jeffrey S Reeves wrote 2,388 Medicare prescriptions that cost $4.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 325 | 335 | 46 | $1.3M |
| Doxycycline Monohydrate Generic | 154 | 289 | 45 | $5,299 |
| Cephalexin Generic | 126 | 276 | 48 | $2,454 |
| Ciprofloxacin Hcl Generic | 109 | 181 | 44 | $1,633 |
| Doxycycline Hyclate Generic | 90 | 180 | 34 | $1,774 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 81 | 96 | 37 | $1,524 |
| Azithromycin Generic | 76 | 135 | 21 | $1,459 |
| Amoxicillin Generic | 75 | 169 | 19 | $1,063 |
| Vancomycin Hcl Generic | 63 | 63 | 20 | $14K |
| Dovato Dolutegravir Sodium/Lamivudine | 60 | 68 | Under 11 | $207K |
| Descovy Emtricitabine/Tenofov Alafenam | 56 | 56 | Under 11 | $118K |
| Ethambutol Hcl Generic | 51 | 86 | 14 | $3,416 |
| Cefepime Hcl Generic | 51 | 51 | 14 | $14K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 44 | 52 | Under 11 | $188K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 41 | 93 | 19 | $467 |
Brand drugs: 814 claims; generic drugs: 1,554 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey S Reeves $528 ($528 in general payments such as food, travel and fees) from 5 companies. The largest payer was Gilead Sciences, Inc. with $302.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.